𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of disopyramide on electrophysiological and mechanical properties of the heart

✍ Scribed by Billy K. Yeh; Pei-Kun Sung; Benjamin J. Scherlag


Publisher
John Wiley and Sons
Year
1973
Tongue
English
Weight
536 KB
Volume
62
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


Studies were performed in whole dog and in isolated superfused canine Purkinje fiber-papillary muscle preparations to investigate mechanisms responsible for the antiarrhythmic effects of disopyramide. Two human left atrial appendages were also studied in oirro. Disopyramide had a potent quinidine-like effect which may explain the antiarrhythmic properties of disopyrarnide. While disopyramide is perhaps at least twice as potent as quinidine in suppressing experimentally induced arrhythmias, disopyramide also has at least proportionally more depressant effect on cardiac mechanical performance in the dog heart.

Keyphrases 0 Disopyramide-ffects on electrophysiological and mechanical properties of the heart. in citro, in uioo

Antiarrhythmic activity, disopyrarnide-effects on electrophysiological and mechanical properties of the heart, ill oirro, in uioo 0 Quinidine-like activity-ffects of disopyramide on itr uitro and in oiuo electrophysiological and mechanical properties of the heart n Cardiac effects, electrophysiological and mechanical4isopyramide


πŸ“œ SIMILAR VOLUMES


Electrophysiological effects of Ageratum
✍ E. A. Conde Garcia; M. Paula Carvalho πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

An extract obtained from the leaves of Ageratum conyzoides L. changed the electrocardiogram, atrial impulse velocity, and coronary vessels resistance on isolated guinea-pig heart. Electrocardiographic alterations were: (a) PR interval increased from 80 AE 1.4 ms to 105 AE 14 ms (p `0.01); (b) QT int

Comparative class 1 electrophysiologic a
✍ Lennart Bergfeldt; Karin Schenck-Gustafsson; Rune Dahlqvist πŸ“‚ Article πŸ“… 1992 πŸ› Springer US 🌐 English βš– 860 KB

During steady-state treatment with disopyramide, its main and active metabolite, mono-N-dealkylated disopyramide, was reported to reach concentrations that were equal to or higher than the parent drug in 25% of 70 evaluated patients. This metabolite has been found to have a more pronounced anticholi